Risk assessment of environmental pollutants is an absolutely essential tool in the overall process of protecting public health. Risk assessment needs reliable scientific information and one source of information is the characterization of metabolic fate and toxicokinetics of environmental pollutants. The aim of in vitro characterization is to produce relevant information on metabolism and interactions to anticipate and ultimately predict what happens in vivo in humans. Because human data is most appropriate to improve human risk assessment, the best option is to rely upon human-derived in vitro models and obtain quantitative toxicokinetics data from in vitro systems for the comparison between species or individuals. In short, based on our studies of pesticide metabolism and interactions, we have used in vitro metabolism data in human and animal hepatic in vitro models and clearance testing data to calculate chemical-specific adjustment factors, instead of fixed uncertainty factors, to be employed as an alternative and more realistic model for human health risk assessment of pesticides and other environmental pollutants. 相似文献
1. The aim of this study was to examine single-dose toxicokinetics of deltamethrin, a broad-spectrum pyrethroid insecticide, for treatment of broiler chickens.
2. Twenty male broiler chickens were used. Animals were divided into two groups, each comprising 10 animals. An intravenous dose of 0.75 mg of deltamethrin/kg body weight was given intravenously to the first group and the same dose (0.75 mg/kg body weight) was administered by intracrop by gavage to the second group. Blood samples were also collected at specified intervals.
3. Serum deltamethrin levels were measured via micro-electron capture detection with gas chromatography equipment. According to the serum deltamethrin level-time curve, deltamethrin tended to distribute according to a two-compartment open model.
4. The half-life at β phase (t1/2β), mean residence time (MRT) and area under the concentration time curve in 0-∞ (AUC0→∞) values after intravenous application of deltamethrin were 4.00 ± 0.76 h, 4.65 ± 0.75 h and 702.27 ± 236.07 ng h/ml, respectively. Furthermore, the absorption half-life (t1/2a), maximal concentration in serum after intracrop administration (Cmax), time needed to reach Cmax (tmax), t1/2β, MRT and AUC0→∞ values after intracrop application of deltamethrin were determined to be 0.18 ± 0.06 h, 19.65 ± 4.58 ng/ml, 0.70 ± 0.10 h, 7.27 ± 1.36 h, 10.46 ± 1.84 h and 153.33 ± 30.83 ng h/ml, respectively. The bioavailability of deltamethrin was 21.83%.
5. It was concluded that deltamethrin was rapidly but incompletely absorbed after intracrop administration and bioavailability was at a low level. The t1/2β and MRT of the deltamethrin were short for both intracrop and intravenous applications, and the risk of toxic and residual effects of deltamethrin is therefore limited. 相似文献